Skip to main content
. 2021 Jun;10(6):2551–2561. doi: 10.21037/tlcr-21-206

Figure 2.

Figure 2

Kaplan-Meier curves for overall survival depending on liver metastasis. (A) Entire study population, P<0.001 [median OS: 9.4 (LM+) vs. 18.4 months (LM–)]. (B) Cytotoxic chemotherapy group, P<0.001 [median OS: 4.4 (LM+) vs. 10.8 months (LM–)]. (C) Targeted therapy, P<0.001 [median OS: 15.6 (LM+) vs. 29.5 months (LM–)]. (D) Immunotherapy, P=0.968 [median OS: 11.7 (LM+) vs. 13.0 months (LM–)]. OS, overall survival; LM, liver metastasis.